The TC20 automated cell counter counts mammalian cells in one simple step using its innovative auto-focus technology and sophisticated cell counting algorithm to produce accurate cell counts in ...

A Bio-Rad TC20 automated cell counter to provide reproducible and accurate cell counts for adherent as well as suspension cells. The TC20 can count single and mixed cell populations and determine ...

This video was supported by Bio-Rad as part of our In Focus on detecting cell proliferation. Check out the In Focus for more information. Video edit by Sandra Kongo-Bacary.

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

A cell counter is a device that automates the manual counting of the number of cells in a sample and is used for standardizing experiments and measuring assay impact. The counters increase ...

Researchers are now applying the technique in drug studies, for cell counting ... and integration effort is California-based Bio-Rad’s recently commercialized QX ONE platform, an updated ...

The newly launched ddPCR assay is gaining a share in the oncology, and cell and therapy markets. Through its agreements with Allegheny Health Network and Oncocyte Corporation, Bio-Rad is advancing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

As per Future Market Insights (FMI) latest analysis, the global cell culture market is projected to total USD 44,593.1 million by 2034, up from USD 27,911.3 million in 2024. It will exhibit a CAGR of ...

A federal jury Monday awarded the former general counsel of Bio-Rad Laboratories $8 million in back pay and damages — which will increase to $11 million — for whistleblower retaliation involving ...

and Bio-Rad Laboratories Inc (NYSE:BIO). The changes will take effect before the opening bell on Sept. 23. Source: InvestingPro Currently, it is trading at a discount of 6.9%, as its price target ...